Recruiting Clinical Trials

Displaying 71 - 80 of 238 result(s)
Study Title Condition Phase Location
A Prospective, Open Label, Multicenter, Single Arm, Phase 2 Study of 177Lu-PSMA-617 in the Treatment of Participants With Progressive PSMA- Positive Metastatic Castration-resistant Prostate Cancer (mCRPC) in Japan Prostate Cancer Phase 2
  • Country: 
    Japan
A Multicenter Open-label Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine (GEP-NET) Tumors, Pheochromocytoma and Paragangliomas (PPGL) Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Phase 2
  • Country: 
    United States
  • Country: 
    Belgium
  • Country: 
    Canada
  • Country: 
    More locations
A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Radiotherapy With or Without Temozolomide and in Recurrent Glioblastoma as Single Agent Glioblastoma Phase 1
  • Country: 
    France
  • Country: 
    Portugal
  • Country: 
    Spain
  • Country: 
    More locations
A One Month, Investigator and Participant Blinded Study to Investigate the Efficacy and Safety of Remibrutinib (LOU064) at Multiple Dose Levels in Adult Participants With Peanut Allergy Allergy, Peanut Phase 2
  • Country: 
    United States
A Phase I, Open-label, Fixed-sequence, Two-period, Crossover, Drug-drug Interaction Study to Investigate the Effect of Efavirenz on the Pharmacokinetics of Ganaplacide and Lumefantrine Combination in Healthy Participants Malaria Phase 1
  • Country: 
    United Kingdom
A 12-week Parallel Group, Randomized, Placebo-controlled, Double-blinded, Multi-center Study to Evaluate Efficacy and Safety of 2 Concentrations of SAF312 Eye Drops (5 mg/ml and 15 mg/ml) Used Twice-daily in the Treatment of Post-operative Corneal In ... Chronic Ocular Pain Phase 2
  • Country: 
    United States
  • Country: 
    Japan
  • Country: 
    United Kingdom
2 Years Prospective Study to Collect Real-life Data On the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non- ... Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiographic Axial Spondyloarthritis Not Given
  • Country: 
    Thailand
A Randomized, Sham-controlled, Double-blind Study to Evaluate the Efficacy and Safety of Intrathecal OAV101 in Type 2 Spinal Muscular Atrophy (SMA) Patients Who Are ≥ 2 to < 18 Years of Age, Treatment Naive, Sitting, and Never Ambulatory Type 2 Spinal Muscular Atrophy Phase 3
  • Country: 
    United States
  • Country: 
    China
  • Country: 
    Malaysia
  • Country: 
    More locations
An Open-label, Single Arm Phase II Study of DFV890 to Assess the Safety, Tolerability and Efficacy in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS) Familial Cold Autoinflammatory Syndrome Phase 2
  • Country: 
    United States
  • Country: 
    France
  • Country: 
    Germany
A Subject and Investigator Blinded, Randomized, Placebo-controlled, Repeat-dose, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis Pulmonary Sarcoidosis Phase 2
  • Country: 
    United States
  • Country: 
    Czech Republic
  • Country: 
    Denmark
  • Country: 
    More locations